🕵️ Emergent Biosolutions Inc. ($EBS)
SEC insider & ownership activity, last 12 months · CIK 1367644 · every row links its SEC filing
Over the last 12 months insiders sold $1.4M with no open-market buying against it. Donald Degolyer sold $318K (Nov–May). No red-flag 8-Ks in the window.
🚨 2 signals active —
planned-vs-executed verdicts, pre-event flags, and cluster context live in the
API and the
alerts bot.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
0 buyers, $0 (0 lots) · 7 sellers, $1.4M (14 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Donald Degolyer | 0 | – | 3 | $318K | May 1, 2026 |
| Glessner Coleen | 0 | – | 1 | $306K | Oct 7, 2025 |
| Ronald Richard | 0 | – | 2 | $263K | Dec 5, 2025 |
| Sujata Tyagi Dayal | 0 | – | 3 | $201K | May 1, 2026 |
| Kathryn Zoon | 0 | – | 2 | $144K | May 1, 2026 |
| Keith Katkin | 0 | – | 1 | $128K | Apr 30, 2026 |
| Williams Paul Anthony | 0 | – | 2 | $59K | Jul 1, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| BlackRock, Inc. | 9.0% | 13G | Jul 28, 2026 | filing ↗ | |
| American Century Investment Management, Inc. | 5.4% | 13G | Aug 14, 2026 | filing ↗ | |
| American Century Companies, Inc. | 5.4% | 13G | Aug 14, 2026 | filing ↗ | |
| Stowers Institute for Medical Research | 5.4% | 13G | Aug 14, 2026 | filing ↗ | |
| Dimensional Fund Advisors LP | 5.3% | 13G | Apr 9, 2026 | filing ↗ | |
| American Century ETF Trust | 5.2% | 13G | Aug 14, 2026 | filing ↗ | |
| State Street Corporation | 5.1% | 13G | Feb 9, 2026 | filing ↗ |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| Paul Williams | $25K | Jul 1, 2026 | filing ↗ |
| Sujata Tyagi Dayal | $116K | May 1, 2026 | filing ↗ |
| Kathryn Zoon | $144K | May 1, 2026 | filing ↗ |
| Donald Degolyer | $130K | May 1, 2026 | filing ↗ |
| Keith Katkin | $128K | Apr 30, 2026 | filing ↗ |
| Paul Williams | $34K | Apr 1, 2026 | filing ↗ |
| Louis W. Sullivan | $360K | Jan 7, 2026 | filing ↗ |
| Louis W. Sullivan | $1.3M | Dec 22, 2025 | filing ↗ |
| Ronald Richard | $392K | Dec 5, 2025 | filing ↗ |
| Donald Degolyer | $188K | Nov 10, 2025 | filing ↗ |
| Sujata Tyagi Dayal | $86K | Nov 7, 2025 | filing ↗ |
| Coleen Glessner | $306K | Oct 7, 2025 | filing ↗ |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Reg FD disclosure (7.01) | Sep 14, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Sep 14, 2026 | filing ↗ |
| Other events (8.01) | Aug 18, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 18, 2026 | filing ↗ |
| Earnings (2.02) | Aug 5, 2026 | filing ↗ |
| Exit or disposal costs (2.05) | Aug 5, 2026 | filing ↗ |
| Officer/director changes (5.02) | Aug 5, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Aug 5, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 5, 2026 | filing ↗ |
| Material agreement (1.01) | Jun 26, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jun 26, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 26, 2026 | filing ↗ |
| Earnings (2.02) | Apr 30, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Apr 30, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 30, 2026 | filing ↗ |
| Shareholder vote (5.07) | Apr 29, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 29, 2026 | filing ↗ |
| Material agreement (1.01) | Apr 16, 2026 | filing ↗ |
| Agreement terminated (1.02) | Apr 16, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | Apr 16, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Apr 16, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 16, 2026 | filing ↗ |
| Earnings (2.02) | Feb 26, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Feb 26, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 26, 2026 | filing ↗ |
| Officer/director changes (5.02) | Feb 25, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Feb 25, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 25, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jan 14, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 14, 2026 | filing ↗ |